CN102671076A - Medicament for treating gout - Google Patents
Medicament for treating gout Download PDFInfo
- Publication number
- CN102671076A CN102671076A CN2012101466692A CN201210146669A CN102671076A CN 102671076 A CN102671076 A CN 102671076A CN 2012101466692 A CN2012101466692 A CN 2012101466692A CN 201210146669 A CN201210146669 A CN 201210146669A CN 102671076 A CN102671076 A CN 102671076A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- radix
- treating gout
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 201000005569 Gout Diseases 0.000 title claims abstract description 14
- 229940079593 drug Drugs 0.000 claims description 6
- 241000903946 Clematidis Species 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 241001529739 Prunella <angiosperm> Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000218158 Clematis Species 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000233932 Sparganium Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 6
- 229940116269 uric acid Drugs 0.000 description 6
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001255 hallux Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a medicament for treating gout. The medicament is prepared from the following bulk pharmaceuticals in parts by weight: 5-10 parts of paris polyphylla, 20-40 parts of common selfheal fruit-spike, 10-30 parts of kudzuvine root, 20-50 parts of dragon's blood, 5-15 parts of large-leaved gentian, 10-30 parts of ommon burreed rhizome and 5-10 parts of clematis root. The medicament is a natural medicament, so that the medicament has the advantages of quick response, good curative effect and freeness from toxic and side effects.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicament of treating gout.
Background technology
Gout is claimed " hyperuricemia " again, the purine metabolism obstacle, and it is a kind of to belong to arthritis.Gout is that the metabolism of the material of purine in the human body gets muddled, and the synthetic increase of uric acid or discharge reduce, and cause hyperuricemia; During the blood uric acid excessive concentration; Uric acid is deposited in joint, cartilage and the kidney with the form of sodium salt, causes to organize foreign body inflammatory reaction, i.e. gout.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of treating gout.
The present invention also aims to provide the method for preparing of the medicine of this treatment gout.
In order to realize the object of the invention; The present invention provides a kind of medicine of treating gout, and it is to be processed by weight by following bulk drugs: Rhizoma Paridis 5-10 part, Spica Prunellae 20-40 part, Radix Puerariae 10-30 part, Sanguis Draxonis 20-50 part, Radix Gentianae Macrophyllae 5-15 part, triangular 10-30 part and Radix Clematidis 5-10 part.
Preferably, it is to be processed by weight by following bulk drugs: 10 parts of 8 parts of Rhizoma Paridis, 30 parts of Spica Prunellaes, 20 parts of Radix Puerariaes, 30 parts of Sanguis Draxonis, 10 parts of Radix Gentianae Macrophyllae, triangular 20 parts and Radix Clematidis.
Use natural drug in the medicine of treatment gout of the present invention, so its advantage that has instant effect, good effect, has no side effect.
The specific embodiment
Below description through the specific embodiment the present invention is described further; But this is not to be limitation of the present invention; Those skilled in the art are according to basic thought of the present invention; Can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get Rhizoma Paridis 80 gram, Spica Prunellae 300 grams, Radix Puerariae 200 grams, Sanguis Draxonis 300 grams, Radix Gentianae Macrophyllae 100 grams, triangular 200 grams and Radix Clematidis 100 grams, pulverize, cross 100 mesh sieves, add sucrose 80 grams then, mixing, packing into promptly gets in 100 bags.
Experimental example
Diagnostic criteria
Reference " internal medicine " (Chen Haozhu. practical internal medicine [M]. the 13rd edition. Beijing: People's Health Publisher; 2009.2364-2370.)) formulate diagnostic criteria; Disease is seen unexpected generation big toe, opens up toe, is stamped, knee joint etc. is located the simple joint red and swollen heat pain; Or urate increases, and the colchicine treatment has specially good effect, and the synovial bursa fluid inspection finds urate crystal.
Choose patient's 80 examples that meet above-mentioned standard, wherein male 40 examples, women 40 examples; 35～75 years old age, average 54 years old.
Use the powder that makes among the embodiment 1, wherein one day 2 times, each one bag, treating 7 days is a course of treatment.
Criterion of therapeutical effect
Reference " traditional Chinese medical science disease diagnosis criterion of therapeutical effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease diagnosis criterion of therapeutical effect [M]. Nanjing: publishing house of Nanjing University, 1994.50-51.) formulate.Cure: arthralgia, swelling disappear, and blood uric acid is normal, do not have recurrence in March.Take a turn for the better: arthralgia, swelling alleviate, and recurrence are arranged in March but treat still can alleviate, and blood uric acid descends.Invalid: no significant changes such as arthralgia, swelling, blood uric acid no change.
Through the observation of a course of treatment is arranged, find that whole patients all meet the treatment standard of healing, and during whole treatment, do not observe tangible untoward reaction.
Claims (3)
1. medicament of treating gout; It is characterized in that it is to be processed by weight by following bulk drugs: Rhizoma Paridis 5-10 part, Spica Prunellae 20-40 part, Radix Puerariae 10-30 part, Sanguis Draxonis 20-50 part, Radix Gentianae Macrophyllae 5-15 part, triangular 10-30 part and Radix Clematidis 5-10 part.
2. the medicament of treatment gout according to claim 1 is characterized in that, it is to be processed by weight by following bulk drugs: 10 parts of 8 parts of Rhizoma Paridis, 30 parts of Spica Prunellaes, 20 parts of Radix Puerariaes, 30 parts of Sanguis Draxonis, 10 parts of Radix Gentianae Macrophyllae, triangular 20 parts and Radix Clematidis.
3. the medicament of treatment gout according to claim 1 and 2 is characterized in that, said medicament is tablet, dispersible tablet, ointment or suppository.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101466692A CN102671076B (en) | 2012-05-14 | 2012-05-14 | Medicament for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101466692A CN102671076B (en) | 2012-05-14 | 2012-05-14 | Medicament for treating gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102671076A true CN102671076A (en) | 2012-09-19 |
| CN102671076B CN102671076B (en) | 2013-11-13 |
Family
ID=46804060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101466692A Active CN102671076B (en) | 2012-05-14 | 2012-05-14 | Medicament for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102671076B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364179A (en) * | 2022-08-29 | 2022-11-22 | 吉林省中医药科学院（吉林省中医药科学院第一临床医院） | Traditional Chinese medicine composition for reducing blood uric acid and preparation method and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
-
2012
- 2012-05-14 CN CN2012101466692A patent/CN102671076B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101703692A (en) * | 2009-11-05 | 2010-05-12 | 卢速江 | Chinese medicinal preparation for treating bone fracture and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 朱洪海等: "风湿病辨证用药规律的研究", 《中华中医药学刊》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115364179A (en) * | 2022-08-29 | 2022-11-22 | 吉林省中医药科学院（吉林省中医药科学院第一临床医院） | Traditional Chinese medicine composition for reducing blood uric acid and preparation method and application thereof |
| CN115364179B (en) * | 2022-08-29 | 2024-02-06 | 吉林省中医药科学院（吉林省中医药科学院第一临床医院） | Traditional Chinese medicine composition for reducing blood uric acid as well as preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102671076B (en) | 2013-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102973674A (en) | Eczema eliminating capsule | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN101991811B (en) | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof | |
| CN100460005C (en) | Medicine composition for treating rheumatism and rheumatoid arthritis | |
| CN102671076B (en) | Medicament for treating gout | |
| CN101181389B (en) | Medicine for treating rheumatoid arthritis | |
| CN103479737A (en) | Traditional Chinese medicine composition for treating senile cutaneous pruritus and application thereof | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN102028922B (en) | Arthritis ointment | |
| CN101264197B (en) | Medicine for treating sciatica | |
| CN101991736B (en) | Medicament for treating osteopathy | |
| CN102579617A (en) | Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same | |
| CN102416153B (en) | Medicament for treating rheumatic arthritis | |
| CN102579789B (en) | Medicine for treating eczema | |
| CN101732450B (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN102961520B (en) | Pharmaceutical composition for treating arthritis and method for preparing pharmaceutical composition for treating arthritis | |
| CN102961727B (en) | Traditional Chinese medicine composition for treating bone diseases in clinical nursing | |
| CN105125704B (en) | A kind of compositions purposes in the medicine of preparation treatment gout | |
| CN100566744C (en) | The migrainous medicine for external use of a kind of treatment | |
| CN102600408A (en) | Medicine for curing hyperplasia of mammary glands | |
| CN102552427B (en) | Suppository for treating chronic pelvic inflammation | |
| CN102488829B (en) | Medicine for treating bone disease | |
| CN101732408B (en) | Chinese medicament for treating angitis and limb angiopathy and preparation method thereof | |
| CN102657731A (en) | Medicament for treating acute eczema | |
| CN104758703A (en) | Medicine for treating primary dysmenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: WU MIN Effective date: 20150121 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272000 JINING, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150121 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 272000 Shandong province Jining City Li Ying Zhen Ji Dai Road No. 8 senior school occupation Building No. 5 unit 101 room Patentee before: Wu Min |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200624 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20200707 Address after: No.10, group 2, hutiantang village, Zhucao Township, Shaodong county, Shaoyang City, Hunan Province Co-patentee after: Zeng Shijie Patentee after: Wang Qi Co-patentee after: Zhu Dajiang Address before: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right |